Equities

Biosino Bio-Technology and Science Inc

Biosino Bio-Technology and Science Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.85
  • Today's Change0.00 / 0.00%
  • Shares traded20.00k
  • 1 Year change-19.81%
  • Beta-0.0852
Data delayed at least 15 minutes, as of May 16 2024 07:31 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION is a China-based company principally engaged in the research and development, manufacture, sales and distribution of in-vitro diagnostics reagent products. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.

  • Revenue in HKD (TTM)312.48m
  • Net income in HKD-12.59m
  • Incorporated1988
  • Employees537.00
  • Location
    Biosino Bio-Technology and Science IncChangping Business Hotel Opposite,No.27,Chaoqian Road, Science and TechnologyIndustrial Park, Changping DistrictBEIJING 102200ChinaCHN
  • Phone+86 1 080117700
  • Fax+86 1 080117026
  • Websitehttps://www.zhongsheng.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Huakang Biomedical Holdings Co Ltd26.62m-6.25m43.54m96.00--0.6602--1.64-0.015-0.0150.0640.13180.3742.692.57277,323.00-8.78-6.96-10.62-8.0164.4966.27-23.48-20.233.82--0.0429---2.77-3.00-88.03---12.03--
Extrawell Pharmaceutical Holdings Ltd68.62m-154.28m93.21m169.00--0.0896--1.36-0.0776-0.07760.02090.43540.05387.479.89379,132.60-12.004.62-12.504.8847.3651.97-223.0773.993.38-0.05140.09680.00-1.82-3.28-1.0133.99121.54--
Sanai Health Industry Group Co Ltd131.98m20.14m103.21m68.004.880.30325.790.7820.00550.00550.03480.0890.3179188.038.441,940,931.003.482.314.723.6528.7734.8710.956.566.22--0.18810.00-30.6016.04-36.23---75.21--
China Health Group Inc23.16m-62.92m111.48m42.00--1.22--4.81-0.0632-0.06320.02330.09210.1438--0.246551,419.30-39.076.84-51.269.5238.3374.98-271.7019.19----0.000.0063.67-18.51-267.82--30.37--
BioSino Bio-technology and Science Inc312.48m-12.59m123.00m537.00--0.5409--0.3936-0.087-0.0872.161.570.49562.791.46581,893.60-3.30-3.84-8.55-10.1744.0640.17-6.66-6.980.9033--0.3956---22.52-0.9513-243.70---16.58--
Canbridge Pharmaceuticals Inc111.20m-409.51m144.45m100.00------1.30-0.965-0.9650.262-0.10130.18754.164.091,111,996.00-69.04---154.20--62.37---368.26--0.6132-41.341.39--30.26--21.64------
Regent Pacific Group Ltd2.48m-195.82m148.46m17.00------59.91-0.8698-0.86980.011-0.05310.0218--12.19145,769.70-172.08-50.00-694.26-59.04-----7,901.89-2,685.21--------574.47-44.7231.24---50.60--
Kontafarma China Holdings Ltd809.11m-28.84m184.42m720.00--0.17444.170.2279-0.0052-0.00520.1450.18920.42063.227.031,123,760.00-3.18-1.33-4.22-2.1858.2554.70-7.55-4.121.28-17.160.2392---9.50-17.3266.02---19.55--
Modern Chinese Medicine Group Co Ltd371.93m52.75m225.00m191.004.270.44023.790.6050.08790.08790.61990.8520.66815.453.801,947,288.009.4720.7610.7525.8230.2841.0214.1820.117.98206.120.00022.54-13.9114.67-44.440.230396.96--
Wai Yuen Tong Medicine Holdings Limited1.36bn36.42m252.02m1.96k7.400.11791.470.18540.03030.03031.131.900.20140.42422.81700,208.600.8907-0.07331.54-0.119649.0842.524.42-0.4560.56631.490.31960.00-7.558.7581.16---12.06--
Shenzhen Neptunus Intrlng Bi tchnq CoLtd1.13bn29.36m253.38m1.44k8.63--11.570.22420.01750.01750.6735--------782,628.40--3.46--5.1339.4849.141.464.29--109.94--0.007.924.19-55.60-12.89-11.10--
PuraPharm Corp Ltd406.86m-106.08m292.96m662.00--1.91--0.7201-0.2685-0.26851.030.38710.43741.044.21614,590.60-11.40-9.20-34.00-19.7053.2459.52-26.07-19.330.3046-2.020.7349---9.20-11.4111.76---13.68--
Hin Sang Group (Interntnl) Hldng Co Ltd92.79m-35.72m311.16m265.00--1.41--3.35-0.0327-0.03270.0850.2020.15242.299.49366,766.80-5.81-4.06-8.74-5.2655.9561.98-38.14-20.980.1129-1.150.5766---32.42-15.45-315.54---36.30--
Data as of May 16 2024. Currency figures normalised to Biosino Bio-Technology and Science Inc's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.